Geissoschizine methyl ether is primarily studied for its potential therapeutic applications in the field of neuroscience and mental health. It is known to interact with various neurotransmitter systems, particularly serotonin receptors, which makes it a subject of interest in the development of treatments for mood disorders such as depression and anxiety. Additionally, its role in modulating neurological pathways suggests potential benefits in addressing conditions like addiction and cognitive dysfunction. Research is ongoing to explore its efficacy and safety in these areas, with a focus on understanding its pharmacological mechanisms and optimizing its use in clinical settings.